Inventor
BRIDGES ALEXANDER JAMES
US29 patents
⚠️ This page may combine multiple inventors who share the name “BRIDGES ALEXANDER JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
24 patentsUS6713484B2Mar 30, 2004
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO291 citations99
US6562818B1May 13, 2003
Irreversible inhibitors of tyrosine kinases
WARNER LAMBERT CO139 citations99
US6521620B1Feb 18, 2003
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO295 citations99
US6127374AOct 3, 2000
Irreversible inhibitors of tyrosine kinases
WARNER LAMBERT CO183 citations99
US6602863B1Aug 5, 2003
Irreversible inhibitors of tyrosine kinases
WARNER LAMBERT CO236 citations98
US6596726B1Jul 22, 2003
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO232 citations98
US6455534B2Sep 24, 2002
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO274 citations98
US6344459B1Feb 5, 2002
Irreversible inhibitors of tyrosine kinases
WARNER LAMBERT CO367 citations98
US6310060B1Oct 30, 2001
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
WARNER LAMBERT CO146 citations98
US6265410B1Jul 24, 2001
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO306 citations98
US6153617ANov 28, 2000
Irreversible bicyclic inhibitors of tyrosine kinases
WARNER LAMBERT CO112 citations98
US6084095AJul 4, 2000
Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO292 citations98
US5679683AOct 21, 1997
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO306 citations98
US5654307AAug 5, 1997
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
WARNER LAMBERT CO479 citations98
US6545030B1Apr 8, 2003
1-heterocycle substituted diarylamines
WARNER LAMBERT CO78 citations97
US6821963B2Nov 23, 2004
4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
WARNER LAMBERT CO52 citations96
US6344455B1Feb 5, 2002
N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, and irreversible inhibitor of tyrosine kinases
WARNER LAMBERT CO213 citations94
US7169816B2Jan 30, 2007
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
WARNER LAMBERT CO30 citations92
US7019033B2Mar 28, 2006
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
WARNER LAMBERT CO26 citations92
US6492363B2Dec 10, 2002
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
WARNER LAMBERT CO14 citations92
US6251943B1Jun 26, 2001
Method of treating or preventing septic shock by administering a MEK inhibitor
WARNER LAMBERT CO18 citations92
US6696440B1Feb 24, 2004
Treatment of asthma with MEK inhibitors
WARNER LAMBERT CO34 citations91
US7030119B1Apr 18, 2006
Method for treating chronic pain using MEK inhibitors
WARNER LAMBERT CO45 citations89
US7786131B2Aug 31, 2010
Pyrimido[5,4-d]pyrimidines derivatives as irreversible inhibitors of tyrosine kinases
WARNER LAMBERT CO6 citations73